COVID-19 has elevated our nation’s stress level. When not managed properly (or without any buffers like social support) stress is associated with increased depression and anxiety. Because COVID-19 ...
There are a number of court cases playing out across the country that could affect the options state and territorial health officials have to limit the spread of disease and promote health and ...
This page features ASTHO’s legal mapping work to plot the legal landscape for public health priorities, beginning with policies intended to prevent overdose.
This ASTHOReport highlights the public health importance of three harm reduction policies and practices to reduce overdoses: facilitating community distribution of naloxone, facilitating community ...
On this episode of Public Health Review, we speak with representatives from public health, public safety, and community harm reduction programs to discuss their perspectives, experiences, and the ...
How Healthcare Providers Can Reduce Stigma to Improve Care for Patients Taking Long-Term Opioid Therapy healthcare providers, reduce stigma, opioid therapy, poor mental health, chronic pain, adverse ...
Opioid Preparedness: Disruptions in Access to Prescription Opioids ASTHO, with support and collaboration from CDC’s Opioid Rapid Response Program (ORRP), helps its members by conducting ...
This ASTHOReport builds on a 2020 document and reflects the current state and federal landscape regarding disruptions, shares updated recommendations on strategies states might use to mitigate risks ...
Four ways the Oregon Health Authority has benefited from aligning its opioid and accreditation-related efforts.
ASTHO Member and Delaware Health Official Karyl Rattay Testifies on Nation’s Opioid Epidemic ARLINGTON, VA—Karyl Rattay, MD, MS, director and state health officer at the Delaware Division of Public ...
ASTHO Legislative Prospectus | Previewing 2024 state legislative actions on opioid overdose prevention.
ASTHO Applauds Administration's Commitment to Combat the Opioid Epidemic ARLINGTON, VA—Michael Fraser, executive director of ASTHO, issued the following response to HHS Secretary Tom Price’s ...
On Jan. 30, 2023, ASTHO released a statement commending the FDA on a new proposal to conduct individual risk assessments for blood donors, a policy that reflects the best available science while not ...
State and Territorial Health Officials Join White House Opioid Conference ARLINGTON, VA—Today, nearly two dozen state and territorial health officials participated in a meeting at the White House, ...
ASTHO Member and West Virginia Health Commissioner Rahul Gupta Testifies on Nation’s Opioid Epidemic ARLINGTON, VA—Rahul Gupta, commissioner and state health officer at the West Virginia Department ...
ASTHO Statement on President Trump's Plan to End the Opioid Epidemic and Address America's "Crisis Next Door" ARLINGTON, VA—Michael Fraser, executive director of ASTHO, issued the ...
New Opioid Reports Support ASTHO Call for Increased Investment in Prevention ARLINGTON, VA—Two reports released this week highlight the continued need for additional resources to combat the national ...
State Health Officials Commend Public Health Emergency Declaration to Address Opioid Epidemic ARLINGTON, VA—Members of the Association of State and Territorial Health Officials (ASTHO) joined ...
The Suicide, Overdose, and Adverse Childhood Experiences Prevention Capacity Assessment Tool (SPACECAT) helps local, state, and territorial health agencies better understand their capacity to address ...